Hims & Hers Health (HIMS) Non Operating Income (2019 - 2026)
Hims & Hers Health (HIMS) reported Non Operating Income of -$23.2 million for Q1 2026, down 994.07% on a YoY basis from $2.6 million in Q1 2025, and down 353.39% sequentially from $9.2 million in Q4 2025.
Hims & Hers Health (HIMS) Non Operating Income (2019 - 2026) Analysis & Trends
Hims & Hers Health (HIMS) has 8 years of Non Operating Income data on file, last reported at -$23.2 million in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income fell 994.07% year-over-year to -$23.2 million; the trailing twelve-month figure through Mar 2026 stood at -$7.5 million (down 175.86% YoY), and the FY2025 full-year result was $18.3 million, up 86.69% from the prior year.
- Non Operating Income declined to -$23.2 million in Q1 2026, from $9.2 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $9.2 million in Q4 2025 to a low of -$23.2 million in Q1 2026.
- A 5-year average of $927117.6 and a median of $1.6 million in 2023 frame the typical range for Non Operating Income.
- Across the five-year window, Non Operating Income soared 349.91% in 2023 and slumped 994.07% in 2026, its largest moves.
- Tracing HIMS's Non Operating Income over 5 years: stood at $577000.0 in 2022, then jumped by 349.91% to $2.6 million in 2023, then surged by 42.33% to $3.7 million in 2024, then jumped by 148.09% to $9.2 million in 2025, then plunged by 353.39% to -$23.2 million in 2026.
- Business Quant data shows HIMS's Non Operating Income at -$23.2 million in Q1 2026, $9.2 million in Q4 2025, and $416000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | -216.00 Mn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 20.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | -7.50 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 53.40 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | - |
| 10 | Hims & Hers Health | 6.44 Bn | 5.69 Bn | 396.79 Mn | -23.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.23 Mn |
| Dec 31, 2025 | 9.17 Mn |
| Sep 30, 2025 | 416,000.00 |
| Jun 30, 2025 | 6.13 Mn |
| Mar 31, 2025 | 2.60 Mn |
| Dec 31, 2024 | 3.70 Mn |
| Sep 30, 2024 | 1.22 Mn |
| Jun 30, 2024 | 2.39 Mn |
| Mar 31, 2024 | 2.50 Mn |
| Dec 31, 2023 | 2.60 Mn |
| Sep 30, 2023 | 1.64 Mn |
| Jun 30, 2023 | 2.07 Mn |
| Mar 31, 2023 | 1.58 Mn |
| Dec 31, 2022 | 577,000.00 |
| Sep 30, 2022 | 1.13 Mn |
| Jun 30, 2022 | 523,000.00 |
| Mar 31, 2022 | 761,000.00 |
| Dec 31, 2021 | -9.68 Mn |
| Sep 30, 2021 | 8.55 Mn |
| Jun 30, 2021 | 8.29 Mn |